Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Liver International, Wiley, Vol. 35, No. 3 ( 2015-03), p. 925-935
    Abstract: Fetuin‐A (α2HS‐glycoprotein), a liver secretory glycoprotein, is known as a transforming growth factor (TGF)‐β1 signalling inhibitor. Serum fetuin‐A concentration is associated with nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease. However, the usefulness of serum fetuin‐A as a predictive fibrosis biomarker in NAFLD patients remains unclear. In this study, we investigated the relationship between circulating fetuin‐A levels and fibrosis‐related markers [platelet count, NAFLD fibrosis score and carotid intima media thickness (IMT)] in subjects with NAFLD. Methods A total of 295 subjects (male, 164; female, 131) who received medical health check‐ups were enrolled in this study. NAFLD was diagnosed using abdominal ultrasonography. Serum fetuin‐A was measured by ELISA. IMT was assessed using a high‐resolution ultrasound scanner. Using recombinant human fetuin‐A, we investigated the effects of fetuin‐A on hepatic stellate cells, which play a pivotal role in the process of hepatic fibrosis. Results Serum fetuin‐A concentration was significantly correlated with platelet count ( R  = 0.19, P  〈  0.01), NAFLD fibrosis score ( R  = −0.25, P   〈  0.01) and mean IMT ( R  = −0.22, P  〈  0.01). Multivariate analyses revealed that the fetuin‐A concentration is a significant and independent determinant of platelet count, NAFLD fibrosis score and mean IMT. Recombinant fetuin‐A suppressed TGF‐β1 signalling and fibrosis‐related gene expression and increased the expression of TGF‐β1 pseudoreceptor bone morphogenic protein and activin membrane‐bound inhibitor (BAMBI). Conclusions Serum fetuin‐A level is associated with liver/vessel fibrosis‐related markers in NAFLD patients. Circulating fetuin‐A could be a useful serum biomarker for predicting liver and vascular fibrosis progression in NAFLD patients.
    Type of Medium: Online Resource
    ISSN: 1478-3223 , 1478-3231
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2015
    detail.hit.zdb_id: 2124684-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages